| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 25 |
| 1 | GEMCITABINE HYDROCHLORIDE | 21 |
| 2 | BEVACIZUMAB | 20 |
| 3 | IBUPROFEN | 19 |
| 4 | IBUPFROFEN | 18 |
| 5 | IBUPROFEN 200 MG | 18 |
| 6 | IBUPROFEN 200MG | 18 |
| 7 | IBUPROFEN CAPSULE | 18 |
| 8 | IBUPROFEN CAPSULES 200 MG | 18 |
| 9 | IBUPROFEN ORAL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CENTELLA ASIATICA WHOLE | 1 | 0.1111 |
| 1 | PALOVAROTENE | 1 | 0.0141 |
| 2 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 3 | PENICILLIN G SODIUM | 2 | 0.0017 |
| 4 | EPCORITAMAB-BYSP | 2 | 0.0015 |
| 5 | SOYBEAN OIL | 1 | 0.0015 |
| 6 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 7 | COAL TAR | 1 | 0.0013 |
| 8 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 9 | SALSALATE | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 32 |
| 2 | Platinum-based Drug [EPC] | 29 |
| 3 | Corticosteroid [EPC] | 28 |
| 4 | Microtubule Inhibitor [EPC] | 26 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 |
| 6 | Opioid Agonist [EPC] | 19 |
| 7 | Kinase Inhibitor [EPC] | 17 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Alkylating Drug [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 7 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |